Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moriau

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cahiers D'Anesthesiologie|May 1, 1972
[Hemostasis disorders in patients with multiple injuries]M Moriau
Acta Clinica Belgica|January 1, 1977
[Vitamin K antagonists and platelet aggregation inhibitors in the prevention of thrombosis]M Moriau, A Ferrant
Acta Clinica Belgica|January 1, 1977
[Blood platelet survival and arterial thrombosis]A Ferrant, M Moriau
Acta Gastro-Enterologica Belgica|April 1, 1996
Importance of a medical treatment in mesenteric vein thrombosis (MVT)M Moriau, M A Azerad
Thrombosis Et Diathesis Haemorrhagica|September 30, 1974
Effects of alpha and beta receptor stimulating and blocking agents on experimental disseminated intravascular coagulationM Moriau, H Noel, R Masure
Thrombosis and Haemostasis|August 28, 1981
Effects of suloctidil on platelet survival time following cardiac valve replacementC Col-de Beys, A Ferrant, M Moriau
Vox Sanguinis|January 1, 1974
Comparative effects of dextrans, gelatin and stable plasma protein solution (SPPS) on the experimental disseminated intravascular coagulation (DIC)M Moriau, J Rodhain, H Noel, et al.
Nouvelle Revue Francaise D'Hematologie|November 1, 1972
[A case of Moschcowitz syndrome associated with a Rickettsia mooseri infection]G Cornu, J L Michaux, M Moriau, et al.
Revue Medicale De Liege|March 15, 1979
[Hematological problems in cardiovascular diseases]D Clément, R Denolin-Reubens, R Krémer, et al.
Thrombosis and Haemostasis|February 26, 1982
Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.)M Moriau, C Col-De Beys, E Pardonge, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cahiers D'Anesthesiologie|May 1, 1972
[Hemostasis disorders in patients with multiple injuries]M Moriau
Acta Clinica Belgica|January 1, 1977
[Vitamin K antagonists and platelet aggregation inhibitors in the prevention of thrombosis]M Moriau, A Ferrant
Acta Clinica Belgica|January 1, 1977
[Blood platelet survival and arterial thrombosis]A Ferrant, M Moriau
Acta Gastro-Enterologica Belgica|April 1, 1996
Importance of a medical treatment in mesenteric vein thrombosis (MVT)M Moriau, M A Azerad
Thrombosis Et Diathesis Haemorrhagica|September 30, 1974
Effects of alpha and beta receptor stimulating and blocking agents on experimental disseminated intravascular coagulationM Moriau, H Noel, R Masure
Thrombosis and Haemostasis|August 28, 1981
Effects of suloctidil on platelet survival time following cardiac valve replacementC Col-de Beys, A Ferrant, M Moriau
Vox Sanguinis|January 1, 1974
Comparative effects of dextrans, gelatin and stable plasma protein solution (SPPS) on the experimental disseminated intravascular coagulation (DIC)M Moriau, J Rodhain, H Noel, et al.
Nouvelle Revue Francaise D'Hematologie|November 1, 1972
[A case of Moschcowitz syndrome associated with a Rickettsia mooseri infection]G Cornu, J L Michaux, M Moriau, et al.
Revue Medicale De Liege|March 15, 1979
[Hematological problems in cardiovascular diseases]D Clément, R Denolin-Reubens, R Krémer, et al.
Thrombosis and Haemostasis|February 26, 1982
Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.)M Moriau, C Col-De Beys, E Pardonge, et al.
Pageof 4